van Tilborg et al. introduce a deep learning model trained to simultaneously predict bioactivity and reconstruct molecules. The model provides a principled measure of distribution shifts, experimentally validated by discovering active inhibitors for two clinically relevant kinase targets.
- Derek van Tilborg
- Luke Rossen
- Francesca Grisoni
